|
⚲
|
| Keyboard |
| Mitchell Kaye | |
|---|---|
| Firm | |
| Address | 10210 North 92nd Street Suite 107 Scottsdale, AZ 85258 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Pentown Capital 1001 LLC | 021-399283 | Director | 1.4 M of 1.4 M |
||
| Aeolus Pharmaceuticals Inc | 021-253346 | Director | 6.7 M of 6.7 M |
||
| Medclaims Liaison LLC | 021-154851 | Executive Officer | 0.4 M | ||
| BVF Partners LP | |||||
| Biotechnology Value Fund II LP | 021-123219 | Executive Officer | 1,406.9 M | 2,495.3 M | |
| Biotechnology Value Fund LP | 021-149395 | Executive Officer | 1,553.1 M | 3,146.4 M | |